![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 46, 33494-33506, November 16, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


¶1
From the
Departments of
Internal Medicine and
Biochemistry and the ¶Department of Veterans Affairs Medical Center and the Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242
CTP:phosphocholine cytidylyltransferase (CCT
) is a proteolytically sensitive enzyme essential for production of phosphatidylcholine, the major phospholipid of animal cell membranes. The molecular signals that govern CCT
protein stability are unknown. An NH2-terminal PEST sequence within CCT
did not serve as a degradation signal for the proteinase, calpain. Calmodulin (CaM) stabilized CCT
from calpain proteolysis. Adenoviral gene transfer of CaM in cells protected CCT
, whereas CaM small interfering RNA accentuated CCT
degradation by calpains. CaM bound CCT
as revealed by fluorescence resonance energy transfer and two-hybrid analysis. Mapping and site-directed mutagenesis of CCT
uncovered a motif (LQERVDKVK) harboring a vital recognition site, Gln243, whereby CaM directly binds to the enzyme. Mutagenesis of CCT
Gln243 not only resulted in loss of CaM binding but also led to complete calpain resistance in vitro and in vivo. Thus, calpains and CaM both access CCT
using a structurally similar molecular signature that profoundly affects CCT
levels. These data suggest that CaM, by antagonizing calpain, serves as a novel binding partner for CCT
that stabilizes the enzyme under proinflammatory stress.
Received for publication, August 6, 2007 , and in revised form, September 4, 2007.
* This work was supported by an American Heart Association predoctoral fellowship award (to B. B. C.), a Merit Review Award from the Department of Veterans Affairs, and National Institutes of Health R01 Grants HL081784, HL068135, HL071040, and HL080229 (to R. K. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.
1 To whom correspondence should be addressed: University of Iowa, Pulmonary and Critical Care Division, C-33K, GH, Dept. of Internal Medicine, Iowa City, IA 52242. Tel.: 319-356-1265; Fax: 319-335-6506; E-mail: ramamallampalli{at}uiowa.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. J. Ryan, B. B. Chen, P. R. Vennalaganti, F. C. Henderson, L. A. Tephly, A. B. Carter, and R. K. Mallampalli 15-Deoxy-{Delta}12,14-prostaglandin J2 Impairs Phosphatidylcholine Synthesis and Induces Nuclear Accumulation of Thiol-modified Cytidylyltransferase J. Biol. Chem., September 5, 2008; 283(36): 24628 - 24640. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |